We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 548

Banking Marijuana-Related Businesses
  • Krieg DeVault
  • USA
  • July 25 2018

On March 21, 2018, Governor Holcomb signed a bill legalizing the sale and use of CBD oil in Indiana.1 CBD oil is derived from industrial hemp, which


DOJ Announces Revised Opioid Anti-Diversion Policy
  • FisherBroyles LLP
  • USA
  • July 16 2018

Last week, the Department of Justice (DOJ) announced that it had finalized new rules to prevent the diversion of prescription opioids in a move


Attorney General Announces Ninth Annual Fraud Takedown Targeting Opioid Epidemic
  • Dinsmore & Shohl LLP
  • USA
  • July 2 2018

On June 28, 2018, Attorney General Jeff Sessions and Department of Health and Human Services (HHS) Secretary Alex M. Azar III announced the ninth year


Sessions’ Justice Department’s Pragmatic Approach to Corporate Accountability
  • Morvillo Abramowitz Grand Iason & Anello PC
  • USA
  • June 18 2018

Many of the administration's enforcement priorities may raise serious concerns for criminal defense lawyers and other champions of legal rights


STATES Act Would Exempt Legal Cannabis from Controlled Substances Act
  • Cozen O'Connor
  • USA
  • June 18 2018

On June 7, Senators Elizabeth Warren, D-Mass., and Cory Gardner, R-Colo., introduced a bill that would permit states to pass their own marijuana laws


Following Repeal of the Individual Mandate, Twenty States Challenge the Affordable Care Act
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • June 15 2018

On February 26, 2018, twenty states (the “Plaintiffs”) jointly filed a lawsuit in the U.S. District Court for the Northern District of Texas


Averting Government Scrutiny in the Wake of an Opioid Prescribing Crackdown
  • Bradley Arant Boult Cummings LLP
  • USA
  • June 15 2018

The scourge of opioid-related addiction and risk is a well-known story among the pain management community. In response to this federally declared


Immigration Newsletter, June 13, 2018
  • Greenspoon Marder LLP
  • USA
  • June 13 2018

On June 6, 2018, USCIS accounced that the number of H-2B visa applications received re-exceeded the one-time supplemental 15,000 FY 2018 H-2B cap. The


Don’t Make a Federal Case Out of It
  • Burns & Levinson LLP
  • USA
  • June 6 2018

Crimson Galeria Limited Partnership et al (the Plaintiffs) vs. Healthy Pharms, Inc. et al (the Defendants), in Civil Action No. 1:17-cv-11696-ADB (the


Boots on the Ground: PIL Task Force Targeting Opioid Providers in the War on Drugs
  • K&L Gates
  • USA
  • April 30 2018

Attorney General Jeff Sessions announced the creation of the Prescription Interdiction & Litigation (“PIL”) Task Force -- which Sessions described as